Bioscience Production

搜索文档
Avantor Q2 Feels The Impact From Bioprocessing Shortfalls, Customer Headwinds, Continued Margin Pressure
Benzinga· 2025-08-02 02:35
Avantor Inc. AVTR stock is trading lower on Friday after the company reported worse-than-expected second-quarter 2025 adjusted EPS.The company reported adjusted EPS of 24 cents, marginally below the consensus of 25 cents.AVTR shares are approaching their 52-week low. Track it now here.The life science tools company reported sales of $1.68 billion, almost in line with the consensus of $1.675 billion.Sales fell 1% compared to the second quarter of 2024. Foreign currency translation had a positive impact of 2% ...
Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-08-01 22:30
For the quarter ended June 2025, Avantor, Inc. (AVTR) reported revenue of $1.68 billion, down 1.1% over the same period last year. EPS came in at $0.24, compared to $0.25 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.68 billion, representing a surprise of +0.38%. The company delivered an EPS surprise of -4%, with the consensus EPS estimate being $0.25.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...